[ad_1]
To increase production capacity, Pfizer and BioNTech have modified the production process, so the number of doses delivered from the Belgian production site will be temporarily reduced next week, the vaccine manufacturer said.
Photo: MTI Photo / Csaba Krizsán
Pfizer and BioNTech have developed a plan to expand production capacity in Europe to produce significantly more vaccines from the second quarter. To this end, certain changes must be made to the manufacturing processes, which will result in a temporary reduction in the number of vaccine doses delivered from the production site in Puurs, Belgium, next week, according to Pfizer.
As of the week of January 25, they will return to the original delivery plan in the European Union, and as of February 15 they will comply with the amount agreed for the first quarter with an increase in deliveries. And starting in the second trimester, the number of doses of vaccines delivered will increase significantly.
The companies will inform the European Commission, EU member states and other countries affected by the change about updated delivery schedules, they wrote.
Per the announcement, Pfizer and BioNTech are working hard to support the introduction of additional vaccination campaigns around the world by not only expanding their own production capacity, but also by hiring additional suppliers and contract manufacturers to increase total production capacity.
[ad_2]
